PON1 and chronic kidney disease: PON1 concentration and its activities on HDL2 and HDL3 subclasses were significantly decreased in patients compared to controls, and that the proportion of PON1 activity on smaller-sized proatherogenic HDL3a and HDL3b particles was significantly increased, probably inferring that the risk for the development of atherosclerosis in CKD patients was elevated.